WatchPAT SpO2 Validation Study

NCT06947447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-08-22

No results posted yet for this study

Summary

Validate the SpO2 accuracy of the WatchPAT compared to arterial blood CO-Oximetry

Conditions

  • Healthy

Interventions

DEVICE

No intervention

Device

Sponsors & Collaborators

  • Element Materials Technology

    collaborator INDUSTRY
  • Itamar-Medical, Israel

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-21
Primary Completion
2025-05-02
Completion
2025-05-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06947447 on ClinicalTrials.gov